Examen de radiation de la TSX – Prometic Life Sciences Inc. (PLI)
Issuer: | Prometic Life Sciences Inc. (the "Company") |
Securities: | Common Shares |
Symbol(s): | PLI |
Delisting Review Status: | TSX has determined that the Company has regained compliance with the requirements for continued listing. |
Additional Information: | Please refer to TSX Bulletin #2019-0278 dated April 16, 2019. |
TSX contact: | Chris Birkett, Director, Toronto Stock Exchange |